Home Compare GMED vs MELI
Stock Comparison · Structural lead, mixed market

Globus Medical vs MercadoLibre: Which Stock Looks Stronger in 2026?

Globus Medical holds the cleaner structural position, with the lead spread across valuation and growth. MercadoLibre does not offset that deficit through any equally strong structural edge elsewhere. The market setup broadly confirms the structural lead — Globus Medical holds the more constructive position. That puts structure and market broadly in agreement — Globus Medical's lead looks more confirmed than conflicted.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The clearest separation starts in valuation, but growth adds another real layer to the result. The overall score gap is 20 points in favour of Globus Medical, Inc..

Trajectory Similarity
0.60
Moderately similar
Peer-set rank: #9
within Globus Medical, Inc.'s functional peer set

These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.

The pair shares a valid long-term profile match, but the trajectories are not especially close.

The clearest structural overlap shows up in revenue growth trajectory and capital structure.

Similarity drivers
revenue growth trajectorycapital structure
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
GMED
Globus Medical, Inc.
69
Peer-Score
Signal qualityHigh
vs
MELI
MercadoLibre, Inc.
49
Peer-Score
Signal qualityMedium

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: GMED vs MELI Profitability 56 46 Stability 44 28 Valuation 81 52 Growth 95 68 GMED MELI
Gap Ranking
#1 Valuation +29
#2 Growth +27
#3 Stability +16
#4 Profitability +10
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for GMED and MELI Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer GMEDMELI Relative valuation Structural strength

Globus Medical, Inc. looks stronger both structurally and on relative valuation.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Valuation
Both rank well on valuation, but Globus Medical, Inc. still holds a clear edge.
Growth
On growth, the edge still sits with Globus Medical, Inc., even though both profiles look solid.
Valuation — Dominant Gap
GMED
81
MELI
52
Gap+29in favour of GMED

The multiple-based pricing edge comes from a forward P/E that is 4.3 turns lower.

What keeps the gap from being one-sided

MercadoLibre, Inc. still carries lower volatility exposure — that difference is real enough to prevent the comparison from becoming one-sided.

What this means for the comparison

The lead is built on both valuation and growth, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the GMED vs MELI comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar valuation-and-growth comparisons

Explore how GMED and MELI each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.